Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AP PA 02

Next Previous
Drug Profile

AP PA 02

Alternative Names: AP-PA-02

Latest Information Update: 03 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Armata Pharmaceuticals
  • Class Antibacterials; Antibronchitics; Bacteriophages
  • Mechanism of Action Cell death stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Bronchiectasis; Pseudomonal infections
  • Phase I/II Staphylococcal infections

Most Recent Events

  • 14 Jan 2025 Armata Pharmaceuticals completes the phase-I/II trial in Staphylococcal infections (Adjunctive treatment) in USA and Australia (IV) (NCT05184764)
  • 19 Dec 2024 Adverse events and antimicrobial data from the phase II Tailwind trial in Pseudomonal infections and Bronchiectasis released by Armata Pharmaceuticals
  • 13 Nov 2024 Armata Pharmaceuticals completes enrolment in the phase-I/II clinical trial in Staphylococcal infections (Adjunctive treatment) in USA (IV) before November 2024 (NCT05184764)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top